desvenlafaxine succinate sustained release

DRUG5 trials

Sponsors

Pfizer, Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Depression - Major Depressive DisorderDepressive Disorder, MajorMajor Depressive DisorderVasomotor Symptoms

Phase 1

Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)

CompletedNCT01190514

PfizerDepression - Major Depressive Disorder

Start: 2010-09-30End: 2010-11-30Updated: 2012-01-27

Phase 3

The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms

CompletedNCT00401245

PfizerVasomotor Symptoms

Start: 2006-12-31End: 2008-01-31Updated: 2011-10-26

Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder

CompletedNCT00824291

Wyeth is now a wholly owned subsidiary of PfizerDepressive Disorder, Major

Start: 2009-02-28End: 2009-11-30Updated: 2011-03-10

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

CompletedNCT01372150

PfizerMajor Depressive Disorder

Start: 2011-11-17End: 2015-03-20Updated: 2019-01-15

Phase 4

Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam

CompletedNCT00952653

PfizerMajor Depressive Disorder

Start: 2010-06-30End: 2010-08-31Updated: 2011-08-15

Related Papers

Trajectories of Function and Symptom Change in Desvenlafaxine Clinical Trials

Journal of Clinical Psychopharmacology2021-06-291 citations

The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial

Journal of Psychopharmacology2016-03-2315 citations

Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder.

2016-01-133 citations

A Post Hoc Analysis of the Effect of Weight on Efficacy in Depressed Patients Treated With Desvenlafaxine 50 mg/d and 100 mg/d

The Primary Care Companion For CNS Disorders2015-06-0411 citations

Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis.

2015-03-267 citations